- Home
- SMG vs AXSM Comparison
SMG vs AXSM Comparison
Compare SMG & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMG
- AXSM
- Stock Information
- Founded
- SMG 1868
- AXSM 2012
- Country
- SMG United States
- AXSM United States
- Employees
- SMG N/A
- AXSM N/A
- Industry
- SMG Agricultural Chemicals
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- SMG Industrials
- AXSM Health Care
- Exchange
- SMG Nasdaq
- AXSM Nasdaq
- Market Cap
- SMG 4.2B
- AXSM 4.7B
- IPO Year
- SMG N/A
- AXSM 2015
- Fundamental
- Price
- SMG $68.40
- AXSM $90.73
- Analyst Decision
- SMG Hold
- AXSM Strong Buy
- Analyst Count
- SMG 7
- AXSM 14
- Target Price
- SMG $77.50
- AXSM $125.93
- AVG Volume (30 Days)
- SMG 807.6K
- AXSM 499.7K
- Earning Date
- SMG 01-29-2025
- AXSM 02-18-2025
- Dividend Yield
- SMG 3.85%
- AXSM N/A
- EPS Growth
- SMG N/A
- AXSM N/A
- EPS
- SMG N/A
- AXSM N/A
- Revenue
- SMG $3,552,700,000.00
- AXSM $338,457,000.00
- Revenue This Year
- SMG $1.13
- AXSM $44.89
- Revenue Next Year
- SMG $2.67
- AXSM $68.41
- P/E Ratio
- SMG N/A
- AXSM N/A
- Revenue Growth
- SMG 0.04
- AXSM 51.47
- 52 Week Low
- SMG $53.43
- AXSM $64.11
- 52 Week High
- SMG $93.90
- AXSM $105.00
- Technical
- Relative Strength Index (RSI)
- SMG 29.93
- AXSM 42.16
- Support Level
- SMG $72.50
- AXSM $89.09
- Resistance Level
- SMG $75.54
- AXSM $94.64
- Average True Range (ATR)
- SMG 2.20
- AXSM 3.64
- MACD
- SMG -0.61
- AXSM -1.14
- Stochastic Oscillator
- SMG 8.79
- AXSM 20.64
About SMG Scotts Miracle-Gro Company (The)
Scotts Miracle-Gro is the largest provider of gardening and lawncare products in the United States. The majority of the company's sales are to large retailers that include Home Depot, Lowe's, and Walmart. Scotts Miracle-Gro can sell its products at a higher price point than its competition because of a well-recognized portfolio of brands that include Miracle-Gro, Roundup, Ortho, Tomcat, and Scotts. Scotts is also the leading supplier of cannabis-growing equipment in North America through its Hawthorne business.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.